HPA-axis effects of nebulised fluticasone propionate compared with oral prednisolone in childhood asthma

Respiratory Medicine

Volumn 96, Issue 8, 2002, Pages 625-631

  Price, J ^a   Lenney, W ^b   Duncan, C ^a   Green, L ^a   Flood, Y ^b   Daley Yates, P ^c   Barnacle, H ^c   Efthimiou, J ^c  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Asthma; Fluticasone propionate; Nebules ; Prednisolone; Urinary cortisol

Indexed keywords

CREATININE; FLUTICASONE PROPIONATE; HYDROCORTISONE; PREDNISOLONE;

ADOLESCENT; ARTICLE; ASTHMA; CANDIDIASIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; CROSSOVER PROCEDURE; DISEASE EXACERBATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG EXPOSURE; DRUG SAFETY; FEMALE; FOLLOW UP; HUMAN; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

EID: 0036695795     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1053/rmed.2002.1323     Document Type: Article

References (22)

1. Global Initiative for Asthma. Global strategy for asthma management and prevention. NHLBI/WHO workshop report March 1993. Bethesda: National Institutes of Health, National Heart, Lung and Blood Institute. Publication number 96-3659B. Revised November 1998.
2. British Thoracic Society. Guidelines on the management of asthma. Thorax 1997; 52: S1-S21.
3. Wolthers OD, Pedersen S. Short term linear growth in asthmatic children during treatment with prednisolone. BMJ 1990; 301: 145-148.
4. Efthimiou J, Barnes P. Effect of inhaled corticosteroids on bones and growth. Eur Respir J 1998; 11: 1167-1177.
5. Zora JA, Zimmerman D, Carey TL, O'Connell EJ, Yunginger JW. Hypothalamic-pituitary-adrenal axis suppression after short-term, high-dose glucocorticoid therapy in children with asthma. J Allergy Clin Immunol 1986; 77: 9-13.
6. Dolan LM, Kesarwala HH, Holroyde JC, Fischer TJ. Short-term, high-dose, systemic steroids in children with asthma: the effect on the hypothalamic-pituitary-adrenal axis. J Allergy Clin Immunol 1987; 80: 81-87.
7. Anderson HR. Trends and district variations in the hospital care of childhood asthma: results of a regional study 1970-85. Thorax 1990; 45: 431-437.
8. Volovitz B, Bentur L, Finkelstein Y, et al. Effectiveness and safety of inhaled corticosteroids in controlling acute asthma attacks in children who were treated in the emergency department: a controlled comparative study with oral prednisolone. J Allergy Clin Immunol 1998; 102: 605-609.
9. Wilson NM, Silverman M. Treatment of acute, episodic asthma in preschool children using intermittent high dose inhaled steroids at home. Arch Dis Child 1990; 65: 407-410.
10. Connett G, Lenney W. Prevention of viral induced asthma attacks using inhaled budesonide. Arch Dis Child 1993; 68: 85-87.
11. Verona E, Ahel V, Williams L, Medley HV. A multicentre, randomised, double-blind, double-dummy, parallel group study comparing efficacy and safety of fluticasone propionate (FP) 500 μg bid delivered by metered dose inhaler (MDI) and spacer device with oral prednisolone. Am J Respir Crit Care Med 1998; 157: A711.
12. Westbroek J, Saarelainen S, Laher M, O'Brien J, Barnacle H, Efthimiou J. Oral steroid sparing effect of two doses of nebulized fluticasone propionate and placebo in patients with severe chronic asthma. Respir Med 1999; 93: 689-699.
13. Falcoz C, Mackie AE, McDowall J, et al. Oral bioavailability of fluticasone propionate in healthy subjects. Br J Clin Phormocol 1996; 41: 459-460.
14. Dahlstrom K, Larsson P. Lung deposition and systemic availability of budesonide inhaled as nebulised suspension from different nebulisers. J Aerosol Med 1995; 8: 79.
15. Agertoft L, Andersen A, Weibull E, Pedersen S. Systemic availability and pharmacokinetics of nebulised budesonide in preschool children. Arch Dis Child 1999; 80: 241-247.
16. Manjra AL, Price J, Lenney W, Hughes S, Barnacle H. Efficacy of nebulised fluticasone propionate compared with oral prednisolone in children with an acute exacerbation of asthma. Respir Med 2000; 94: 1206-1214.
17. Hoffmann-Streb A, L'Allemand D, Niggemann B, Buttner P, Wahn U. Adrenal cortex function in children with bronchial asthma in fluticasone therapy. Monatsschr Kinderheilk 1993; 141: 508-512.
18. Brutsche MH, Carlan Brutsche I, Munavvar M, et al. Pharmacokinetics and systemic effects of inhaled fluticasone propionate (FP) are different in asthmatics (A) and normal volunteers (N). Eur Respir J 1999; 14: 345s.
19. Hallett C. Corticosteroid treatment of asthma: now at the crossroads. Respir Med 1999; 93: 292-294.
20. Harding SM. The human pharmacology of fluticasone propionate. Respir Med 1990; 84 (Suppl A): 25-29.
21. Devidayal, Singhi S, Kumar L, Jayshree M. Efficacy of nebulized budesonide compared to oral prednisolone in acute bronchial asthma. Acta Paediatr 1999; 88: 835-840.
22. Daugbjerg P, Brenoe E, Forchhammer H, et al. A comparison between nebulized terbutaline, nebulized corticosteroid and systemic corticosteroid for acute wheezing in children up to 18 months of age. Acta Paediatr 1993; 82: 547-551.